Attached files

file filename
EX-31.2 - EX-31.2 - NCI, Inc.d153119dex312.htm
EX-31.1 - EX-31.1 - NCI, Inc.d153119dex311.htm
EX-32.1 - EX-32.1 - NCI, Inc.d153119dex321.htm
Table of Contents

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 10-Q

 

 

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 or 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

FOR THE QUARTER ENDED MARCH 31, 2016

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

Commission File Number 000-51579

 

 

 

LOGO

NCI, Inc.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware   20-3211574

(State or other jurisdiction of

incorporation or organization)

 

(I.R.S. Employer

Identification No.)

11730 Plaza America Drive

Reston, Virginia

  20190-4764
(Address of principal executive offices)   (Zip Code)

Registrant’s telephone number, including area code: (703) 707-6900

 

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    x  Yes    ¨  No

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    x  Yes    ¨  No

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definition of “large accelerated filer,” “accelerated filer,” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

 

Large accelerated filer   ¨    Accelerated filer   x
Non-accelerated filer   ¨  (Do not check if a smaller reporting company)    Smaller Reporting Company   ¨

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ¨  Yes    x  No

As of April 25, 2016, there were 9,004,397 shares outstanding of the registrant’s Class A common stock. In addition, there are 4,500,000 shares outstanding of the registrant’s Class B common stock, which are convertible on a one-for-one basis into shares of Class A common stock.

 

 

 


Table of Contents

NCI, INC.

 

         PAGE  
PART I:  

UNAUDITED FINANCIAL INFORMATION

     1   
Item 1.  

Condensed Consolidated Financial Statements

     1   
Item 2.  

Management’s Discussion and Analysis of Financial Condition and Results of Operations

     9   
Item 3.  

Quantitative and Qualitative Disclosures About Market Risk

     13   
Item 4.  

Controls and Procedures

     14   
PART II:  

OTHER INFORMATION

     15   
Item 1.  

Legal Proceedings

     15   
Item 1A.  

Risk Factors

     15   
Item 2.  

Unregistered Sales of Equity Securities and Use of Proceeds

     15   
Item 3.  

Defaults Upon Senior Securities

     15   
Item 4.  

Mine Safety Disclosures

     15   
Item 5.  

Other Information

     15   
Item 6.  

Exhibits

     16   
 

Signatures

     17   


Table of Contents

PART 1

FINANCIAL INFORMATION

Item 1. Condensed Consolidated Financial Statements

NCI, INC.

CONDENSED CONSOLIDATED STATEMENTS OF INCOME

(UNAUDITED)

(in thousands, except per share data)

 

     Three months ended March 31,  
     2016      2015  

Revenue

   $ 83,655       $ 80,968   

Operating expenses:

     

Cost of revenue

     69,987         67,602   

General and administrative expenses

     6,129         6,629   

Depreciation and amortization

     1,792         2,089   

Acquisition and integration related expenses

     —           230   
  

 

 

    

 

 

 

Total operating expenses

     77,908         76,550   
  

 

 

    

 

 

 

Operating income

     5,747         4,418   

Interest expense, net

     190         238   
  

 

 

    

 

 

 

Income before income taxes

     5,557         4,180   

Provision for income taxes

     2,224         1,775   
  

 

 

    

 

 

 

Net income

   $ 3,333       $ 2,405   
  

 

 

    

 

 

 

Earnings per common and common equivalent share:

     

Basic:

     

Weighted average shares outstanding

     13,153         12,968   

Net income per share

   $ 0.25       $ 0.19   
  

 

 

    

 

 

 

Diluted:

     

Weighted average shares outstanding

     13,867         13,601   

Net income per share

   $ 0.24       $ 0.18   
  

 

 

    

 

 

 

Cash dividend declared and paid per share

   $ 0.15       $ 0.12   
  

 

 

    

 

 

 

The accompanying notes are an integral

part of these condensed consolidated financial statements

 

1


Table of Contents

NCI, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(UNAUDITED)

(in thousands, except par value)

 

     As of
March 31,
2016
    As of
December 31,
2015
 

Assets:

    

Current assets:

    

Cash and cash equivalents

   $ 388      $ 233   

Accounts receivable, net

     68,936        60,044   

Prepaid expenses and other current assets

     5,847        3,447   
  

 

 

   

 

 

 

Total current assets

     75,171        63,724   

Property and equipment, net

     6,156        6,698   

Other assets

     1,605        1,548   

Deferred tax assets, net

     38,722        38,789   

Intangible assets, net

     18,320        19,231   

Goodwill

     33,878        33,878   
  

 

 

   

 

 

 

Total assets

   $ 173,852      $ 163,868   
  

 

 

   

 

 

 

Liabilities and stockholders’ equity:

    

Current liabilities:

    

Current portion of long-term debt

   $ 20,500      $ —     

Accounts payable

     17,955        19,693   

Accrued salaries and benefits

     15,993        18,977   

Deferred revenue

     2,458        2,217   

Other accrued expenses

     5,774        3,843   
  

 

 

   

 

 

 

Total current liabilities

     62,680        44,730   
  

 

 

   

 

 

 

Long-term debt

     —          10,000   

Other long-term liabilities

     2,798        2,578   
  

 

 

   

 

 

 

Total liabilities

     65,478        57,308   
  

 

 

   

 

 

 

Stockholders’ equity:

    

Class A common stock, $0.019 par value—37,500 shares authorized; 9,921 shares issued and 9,004 shares outstanding as of March 31, 2016, and 9,843 shares issued and 8,961 shares outstanding as of December 31, 2015

     188        187   

Class B common stock, $0.019 par value—12,500 shares authorized; 4,500 shares issued and outstanding as of March 31, 2016 and December 31, 2015

     86        86   

Additional paid-in capital

     77,069        76,569   

Treasury stock at cost—917 shares of Class A common stock as of March 31, 2016 and December 31, 2015

     (8,331     (8,331

Retained earnings

     39,362        38,049   
  

 

 

   

 

 

 

Total stockholders’ equity

     108,374        106,560   
  

 

 

   

 

 

 

Total liabilities and stockholders’ equity

   $ 173,852      $ 163,868   
  

 

 

   

 

 

 

The accompanying notes are an integral

part of these condensed consolidated financial statements

 

2


Table of Contents

NCI, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(UNAUDITED)

(in thousands)

 

     Three months ended March 31,  
     2016     2015  

Cash flows from operating activities:

    

Net income

   $ 3,333      $ 2,405   

Adjustments to reconcile net income to net cash provided by operating activities:

    

Depreciation and amortization

     1,792        2,089   

Share-based compensation

     329        370   

Deferred income taxes

     67        73   

Changes in operating assets and liabilities:

    

Accounts receivable, net

     (8,892     5,242   

Prepaid expenses and other assets

     (2,458     691   

Accounts payable

     (1,738     (1,035

Accrued expenses and other liabilities

     (591     (3,606
  

 

 

   

 

 

 

Net cash (used in) provided by operating activities

     (8,158     6,229   
  

 

 

   

 

 

 

Cash flows from investing activities:

    

Purchases of property and equipment

     (339     (251

Cash paid for acquisition, net of cash acquired

     —          (56,657
  

 

 

   

 

 

 

Net cash used in investing activities

     (339     (56,908
  

 

 

   

 

 

 

Cash flows from financing activities:

    

Borrowings under credit facility

     47,233        72,340   

Repayments on credit facility

     (36,733     (45,340

Proceeds from exercise of stock options

     172        127   

Dividends paid

     (2,020     (1,561
  

 

 

   

 

 

 

Net cash provided by financing activities

     8,652        25,566   
  

 

 

   

 

 

 

Net change in cash and cash equivalents

     155        (25,113

Cash and cash equivalents, beginning of period

     233        25,819   
  

 

 

   

 

 

 

Cash and cash equivalents, end of period

   $ 388      $ 706   
  

 

 

   

 

 

 

Supplemental disclosure of cash flow information:

    

Cash paid during the period for:

    

Interest

   $ 104      $ 211   
  

 

 

   

 

 

 

Income taxes

   $ 327      $ 541   
  

 

 

   

 

 

 

The accompanying notes are an integral

part of these condensed consolidated financial statements

 

3


Table of Contents

NCI, INC.

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(UNAUDITED)

1. Basis of Presentation

The accompanying unaudited condensed consolidated financial statements of NCI, Inc. and its subsidiaries (“NCI” or “the Company”) have been prepared in accordance with generally accepted accounting principles in the U. S. (“GAAP”) for interim financial information and pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). As a result, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management, the accompanying unaudited interim consolidated financial statements reflect all adjustments necessary to fairly present the Company’s financial position as of March 31, 2016 and its results of operations and cash flows for the three months ended March 31, 2016 and 2015, which consists of normal and recurring adjustments. The information disclosed in the notes to the financial statements for these periods is unaudited. The current period’s results of operations are not necessarily indicative of results that may be achieved for any future period. All numbers in tables are presented in thousands except share and per share numbers. For further information, refer to the financial statements and footnotes included in NCI’s Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the SEC.

Recently Issued Accounting Pronouncements

On November 20, 2015, the FASB issued ASU 2015-17, Balance Sheet Classification of Deferred Taxes. To simplify the presentation of deferred income taxes, the amendments in this ASU require that deferred tax assets and liabilities be classified as noncurrent in a classified balance sheet. As permitted, we elected to early adopt this ASU using the retrospective approach, effective with our current Form 10-Q filing for March 31, 2016. As a result of adopting this ASU, we recast our December 31, 2015 balance sheet by decreasing deferred tax assets, net, by $4,034 thousand, and increased the line item for non-current deferred tax assets, net, in the amount of $4,034 thousand. There was no impact to our December 31, 2015 consolidated statements of income, changes in stockholders’ equity, or cash flows.

At March 31, 2016, the adoption of ASU 2015-17 resulted in a decrease of $4,034 thousand in deferred tax assets, net, and a corresponding increase to non-current deferred tax assets, net, in our condensed consolidated balance sheet. The adoption of ASU 2015-17 had no impact on our condensed consolidated statements of income or cash flows for the three month period ended March 31, 2016.

In February 2016, the FASB issued ASU 2016-02, which requires the recognition of right-to-use assets and lease liabilities arising from capital leases and operating leases in the statement of comprehensive income and the statement of financial position, respectively. The Company will adopt the standard effective January 1, 2019 and does not anticipate that this new accounting guidance will have a material impact on its consolidated statement of operations. The Company has not yet completed its evaluation of the impact on the consolidated balance sheet. The actual impact will depend on the Company’s lease portfolio at the time of adoption.

In March 2016, the FASB issued ASU 2016-08, which clarifies the implementation guidance on principal versus agent considerations under the new revenue recognition standard, ASU 2014-09, Revenue from Contracts with Customers. In April 2016, the FASB issued ASU 2016-10, which clarifies the implementation guidance on identifying promised goods or services from a principal and agent perspective. The Company will adopt the standard effective January 1, 2018. The Company is continuing to evaluate the full effect that ASU 2014-09 and related subsequent updates will have on its consolidated financial statements and related disclosures.

In March 2016, the FASB issued ASU 2016-09, which simplifies several aspects of the accounting for share-based payments, including immediate recognition of all excess tax benefits and deficiencies in the income statement, changing the threshold to qualify for equity classification up to the employees’ maximum statutory tax rates, allowing an entity-wide accounting policy election to either estimate the number of awards that are expected to vest or account for forfeitures as they occur, and clarifying the classification on the statement of cash flows for the excess tax benefit and employee taxes paid when an employer withholds shares for tax-withholding purposes. The Company is evaluating the full effect that ASU 2016-09 will have on its consolidated financial statements and will adopt the standard effective January 1, 2017.

2. Business Overview

NCI is a leading provider of enterprise solutions and services to U.S. defense, intelligence, health care and civilian government agencies. We have the expertise and proven track record to solve our customers’ most important and complex mission challenges through technology and innovation. Our team of highly skilled professionals focuses on delivering cost-effective solutions and services in the areas of agile software application and systems development/integration; cybersecurity and information assurance; engineering and logistics support; enterprise information management and advanced analytics; cloud computing and IT infrastructure optimization; health IT and medical support; IT service management; and modeling, simulation and training. Headquartered in Reston, Virginia, we have more than 2,000 employees operating at more than 100 locations worldwide. The majority of the Company’s revenue was derived from contracts with the U.S. Federal Government, directly as a prime contractor or as a subcontractor. NCI primarily conducts business throughout the U. S. The Company reports operating results and financial data as one reportable segment.

For the three months ended March 31, 2016, the Company generated approximately 63% of revenue from the Department of Defense, including agencies within the intelligence community, and approximately 37% of revenue from federal civilian agencies. For the three months ended March 31, 2015, the Company generated approximately 60% of revenue from the Department of Defense, including agencies within the intelligence community, and approximately 40% of revenue from federal civilian agencies.

NCI’s Program Executive Office Soldier (“PEO Soldier”) contract is the Company’s largest revenue-generating contract and accounted for approximately 16% and 10% of revenue for the three months ended March 31, 2016 and 2015, respectively. The Company’s PEO Soldier program is a cost-plus fee contract consisting of a base period and four option periods for a total term of five years, which commenced in October 1, 2015. NCI’s Cyber Network Operations and Security Support (CNOSS) program, supporting the U.S. Army Network Enterprise Technology Command accounted for approximately 10% and 7% of revenue for the three months ended March 31, 2016, and 2015, respectively. This cost-plus-fixed-fee, single award indefinite delivery indefinite quantity contract consists of a 12-month base period with two one-year option periods and one six-month option period, and commenced in October 2014.

 

4


Table of Contents

3. Earnings Per Share

Basic earnings per share exclude dilution and are computed by dividing net income by the weighted average number of common shares outstanding for the period. Diluted earnings per share reflect potential dilution that could occur if securities or other contracts to issue common stock were exercised or converted into common stock. Diluted earnings per share include the incremental effect of stock options calculated using the treasury stock method. Shares that are anti-dilutive are not included in the computation of diluted earnings per share. For the three months ended March 31, 2016 and 2015, approximately 30,000 and 109,000 shares, respectively, were not included in the computation of diluted earnings per share, because to do so would have been anti-dilutive. The following details the computation of basic and diluted earnings per common share (Class A and Class B) for the three months ended March 31, 2016 and 2015.

 

     Three months ended March 31,  
     2016      2015  

Net Income

   $ 3,333       $ 2,405   
  

 

 

    

 

 

 

Weighted average number of basic shares outstanding during the period

     13,153         12,968   

Effect of dilutive potential common shares

     714         633   
  

 

 

    

 

 

 

Weighted average number of diluted shares outstanding during the period

     13,867         13,601   
  

 

 

    

 

 

 

Basic earnings per share

   $ 0.25       $ 0.19   
  

 

 

    

 

 

 

Diluted earnings per share

   $ 0.24       $ 0.18   
  

 

 

    

 

 

 

4. Accounts Receivable

Accounts receivable consists of billed and unbilled amounts. The following table details accounts receivable at the end of each period:

 

     As of  
     March 31,
2016
     December 31,
2015
 

Billed receivables

   $ 24,732       $ 23,621   

Unbilled receivables:

     

Amounts billable at end of period

     30,146         27,185   

Other

     14,800         9,980   
  

 

 

    

 

 

 

Total unbilled receivables

     44,946         37,165   
  

 

 

    

 

 

 

Total accounts receivable

     69,678         60,787   

Less: Allowance for doubtful accounts

     742         742   
  

 

 

    

 

 

 

Total accounts receivable, net

   $ 68,936       $ 60,044   
  

 

 

    

 

 

 

Other unbilled receivables primarily consist of amounts that will be billed upon milestone completions and other accrued amounts that cannot be billed as of the end of the period. Substantially all unbilled receivables are expected to be billed and collected within the next 12 months.

5. Property and Equipment

The following table details property and equipment at the end of each period:

 

     As of  
     March 31,
2016
     December 31,
2015
 

Property and equipment

     

Furniture and equipment

   $ 26,878       $ 26,573   

Leasehold improvements

     9,357         9,323   

Real property

     549         549   
  

 

 

    

 

 

 
     36,784         36,444   

Less: Accumulated depreciation and amortization

     30,628         29,746   
  

 

 

    

 

 

 

Property and equipment, net

   $ 6,156       $ 6,698   
  

 

 

    

 

 

 

Depreciation and amortization expense for the three months ended March 31, 2016 and 2015 was $0.9 million and $1.0 million, respectively.

 

5


Table of Contents

6. Intangible Assets

The following table details intangible assets at the end of each period:

 

     As of  
     March 31,
2016
     December 31,
2015
 

Contract and customer relationships

   $ 39,594       $ 39,594   

Developed software

     1,113         1,113   

Less: Accumulated amortization

     (22,387      (21,476
  

 

 

    

 

 

 

Intangible assets, net

   $ 18,320       $ 19,231   
  

 

 

    

 

 

 

Amortization expense of intangible assets for the three months ended March 31, 2016 and 2015 was $0.9 million and $1.1 million, respectively. Intangible assets are primarily amortized on a straight line basis over periods ranging from seven to 11 years. Expected amortization expense for the remainder of the fiscal year ending December 31, 2016, and for each of the fiscal years thereafter, is as follows:

 

For the year ending December 31,

      

2016 (remaining nine months)

   $ 2,734   

2017

     3,632   

2018

     3,149   

2019

     3,049   

2020

     3,027   

Thereafter

     2,729   
  

 

 

 
   $ 18,320   
  

 

 

 

7. Share-Based Payments

During the three months ended March 31, 2016, the Company did not grant any stock options to purchase shares of Class A common stock. During the three months ended March 31, 2016, 38,332 stock options were exercised at a weighted-average price of $4.48. As of March 31, 2016, there were approximately 1,509,501 stock options outstanding. During the three months ended March 31, 2016, 5,000 restricted shares were granted, and 6,250 restricted shares vested. As of March 31, 2016, there were 320,000 shares of restricted stock outstanding.

The following table summarizes stock compensation expense allocated to cost of revenue and general and administrative costs for the three months ended March 31, 2016 and 2015:

 

     Three months ended March 31,  
     2016      2015  

Cost of revenue

   $ 79       $ 63   

General and administrative

     250         307   
  

 

 

    

 

 

 
   $ 329       $ 370   
  

 

 

    

 

 

 

As of March 31, 2016, there was approximately $3.6 million of total unrecognized compensation cost related to unvested stock compensation arrangements. This cost is expected to be fully amortized over the next five years, with approximately $0.7 million, $0.9 million, $0.8 million, $0.7 million and $0.5 million amortized during the remainder of 2016, and the full years of 2017, 2018, 2019, and 2020, respectively. The cost of stock compensation is included in the Company’s Condensed Consolidated Statements of Income and expensed over the service period of the options.

 

6


Table of Contents

8. Debt

The Company’s senior credit facility, amended in December 2014, and referred to herein as the “credit facility,” consists of a revolving line of credit with a borrowing capacity of up to an $80.0 million principal amount and a $45.0 million accordion feature allowing us to increase our borrowing capacity to up to a $125.0 million principal amount, subject to obtaining commitments for the incremental capacity from existing or new lenders. The outstanding borrowings are collateralized by a security interest in substantially all of the Company’s assets. The lenders also require a direct assignment of all contracts at the lenders’ discretion. The outstanding balance under the credit facility accrues interest based on one-month LIBOR plus an applicable margin, ranging from 210 to 310 basis points, based on the ratio of the Company’s outstanding senior funded debt to Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA) as defined in the credit facility agreement. The credit facility expires on January 31, 2017. Accordingly all borrowings are classified as current liabilities as they are due and payable within the next 12 months.

The credit facility contains various covenants that limit, among other things, the Company’s ability to incur or guarantee additional debt; make certain distributions, investments and other restricted payments, including limits on cash dividends on the Company’s outstanding common stock or equivalent equity interests; enter into transactions with certain affiliates; create or permit certain liens; and consolidate, merge, or sell assets. In addition, the credit facility contains certain financial covenants that require the Company to maintain a minimum fixed charge coverage ratio, maintain a minimum funded debt to earnings ratio; and limit capital expenditures below certain thresholds. As of March 31, 2016, the Company was in compliance with all of its loan covenants.

The credit facility allows the Company to use borrowings thereunder of up to $17.5 million to repurchase outstanding shares of Class A common stock. No stock repurchases took place in the three months ended March 31, 2016. At March 31, 2016, $16.7 million was remaining under the board of directors’ authorization for share repurchases.

During the first quarter of 2016, NCI had a weighted average outstanding loan balance of $16.5 million which accrued interest at a weighted average borrowing rate of 2.5%. During the first quarter of 2015, NCI had a weighted average outstanding loan balance of $28.6 million which accrued interest at a weighted average borrowing rate of 2.3%.

As of March 31, 2016, the outstanding balance under the credit facility was $20.5 million and interest accrued at a rate of one-month LIBOR plus 210 basis points, or 2.5%.

9. Computech Acquisition

On January 1, 2015, the Company completed its purchase of 100% of the outstanding stock of Computech, Inc. (“Computech”), a leader in agile and lean application software development and IT operations and maintenance, for approximately $56.7 million, net of cash acquired.

The acquisition has been accounted for under the acquisition method of accounting, which requires the total purchase consideration to be allocated to the assets acquired and liabilities assumed based on estimates of fair value. The excess of the purchase consideration over the amounts assigned to tangible or intangible assets acquired and liabilities assumed is recognized as goodwill. Total acquisition and integration related costs through March 31, 2015 were approximately $0.2 million.

Allocation of Purchase Price

NCI has completed the valuation of the assets acquired and liabilities assumed of Computech. The fair values assigned to the intangible assets acquired were based on estimates, assumptions, and other information compiled by management, including independent valuations that utilized established valuation techniques. Based on the Company’s valuation, the total consideration of approximately $56.7 million, net of $3.3 million of cash acquired, has been allocated to assets acquired (including identifiable intangible assets and goodwill) and liabilities assumed, as follows:

 

Accounts receivable and other assets

     8,407   

Goodwill

     33,878   

Definite-life intangible assets

     19,720   

Accrued salary and benefits

     (4,112

Other accrued expenses

     (1,236
  

 

 

 
   $ 56,657   
  

 

 

 

 

7


Table of Contents

The definite life intangibles recognized in the allocation of the Computech purchase price consists of $18.6 million in contracts and customer relationships and $1.1 million in developed software. The fair value of the definite-lived intangible asset for contracts and customer relationships is based on existing customer contracts and anticipated follow-on contracts with existing customers and will be amortized on a straight-line basis over its expected life of seven years. The fair value of the definite-lived intangible asset for developed software will be amortized on a straight-line basis over its expected useful life of three years.

All goodwill and intangible asset amortization related to the acquisition of Computech is expected to be deductible for income tax purposes.

10. Dividends

Our board of directors declared and the Company paid the following dividends during the periods presented:

 

Declaration Date

   Dividend
Per Share
    

Record Date

   Total Amount     

Payment Date

February 11, 2015

   $ 0.12       February 20, 2015    $ 1,561       March 13, 2015

February 8, 2016

   $ 0.15       February 26, 2016    $ 2,020       March 18, 2016

11. Related Party Transactions

The Company purchased services under a subcontract from Renegade Technology Systems, Inc., which is a government contractor wholly-owned by Rajiv Narang, the son of Charles K. Narang, Chairman of the Board. For the three months ended March 31, 2016 and 2015, the expense incurred under this agreement was approximately $157,000 and $166,000, respectively. As of March 31, 2016 and 2015, outstanding amounts due to Renegade Technology Systems, Inc. under this agreement were $47,410 and $68,030, respectively.

12. Contingencies

Government Audits

Payments to the Company on U.S. Federal Government contracts are subject to adjustment upon audit by various agencies of the U.S. Federal Government. Audits of costs and the related payments have been performed through 2007 for NCI Information Systems, Inc., the Company’s primary corporate vehicle for government contracting. In the opinion of management, the final determination of costs and related payments for unaudited years will not have a material effect on the Company’s financial position, results of operations, or liquidity.

Litigation

The Company is party to various legal actions, claims, government inquiries, and audits resulting from the normal course of business. The Company believes that the probability is remote that any resulting liability will have a material effect on the Company’s financial position, results of operations, or liquidity.

 

8


Table of Contents

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form 10-Q, including the section titled “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains forward-looking statements regarding our business, financial condition, results of operations, and prospects. There are statements made herein, which may not address historical facts and, therefore, could be interpreted to be forward-looking statements as that term is defined in the Private Securities Litigation Reform Act of 1995. Such statements are subject to factors that could cause actual results to differ materially from anticipated results. The factors that could cause actual results to differ materially from those anticipated include, but are not limited to, the following:

 

    our dependence on our contracts with U.S. Federal Government agencies, particularly within the U.S. Department of Defense, for the majority our revenue; delays performing work under our contracts due to bid protests; changes in U.S. Federal Government spending priorities; changes in contract type, particularly changes from cost-plus fee or time-and-material type contracts to firm fixed-price type contracts

 

    a reduction in the overall U.S. defense budget, volatility in spending authorizations for defense and intelligence-related programs by the U.S. Federal Government or a shift in spending to programs in areas where we do not currently provide services

 

    delays in the U.S. Federal Government appropriations process, or budgetary cuts resulting from Congressional committee recommendations or automatic sequestration under the Budget Control Act of 2011; U.S. Federal Governmental shutdowns (such as the shutdown that occurred during the U.S. Federal Government’s 1996 and 2013 fiscal years); and other potential delays in the U.S. Federal Government appropriations process

 

    changes in U.S. Federal Government programs or requirements, including the increased use of small business providers

 

    failure to achieve contract awards in connection with recompetes for present business and/or competition for new business

 

    U.S. Federal Government agencies more frequently awarding contracts on a technically acceptable/lowest cost basis in order to reduce expenditures

 

    adverse results of U.S. Federal Government audits of our government contracts

 

    competitive factors, such as pricing pressures and competition to hire and retain employees (particularly those with security clearances)

 

    failure to identify and successfully integrate acquired companies or businesses into our operations or to realize any accretive or synergistic effects from such acquisitions, or effectively integrate acquisitions appropriate to the achievement of our strategic plans

 

    economic conditions in the United States, including conditions that result from terrorist activities or war

 

    material changes in policies, laws, or regulations applicable to our businesses, particularly legislation affecting (i) U.S. Federal Government contracts for services, (ii) outsourcing of activities that have been performed by the U.S. Federal Government, (iii) U.S. Federal Government contracts containing organizational conflict of interest clauses, (iv) delays related to agency specific funding freezes, and (v) competition for task orders under Government Wide Acquisition Contracts (“GWAC”), agency-specific Indefinite Delivery/Indefinite Quantity (“IDIQ”) contracts and/or schedule contracts with the General Services Administration

 

    the U.S. Federal Government’s “insourcing” of previously contracted support services and the realignment of funds to non-defense related programs

 

    our ability to achieve the objectives of near-term or long-range business plans, particularly revenue growth, and the ability to realize benefits from future deferred tax assets; and

 

    risk of contract non-performance or termination

Some of these important factors are outlined under Item 1A. Risk Factors and elsewhere in our Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the Securities and Exchange Commission (“SEC”), and from time to time in other filings with the SEC, such as our Current Reports on Forms 8-K and Quarterly Reports on Form 10-Q. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee our future results, level of activity, or performance. We undertake no obligation to update publicly or revise any forward-looking statements. You should not place undue reliance on any forward-looking statements.

In this document, unless the context indicates otherwise, the terms “Company,” “NCI,” “we,” “us,” and “our” refer to NCI, Inc., a Delaware corporation, and, where appropriate, its subsidiaries.

 

9


Table of Contents

OVERVIEW

We are a provider of information technology (“IT”) and professional services and solutions primarily to U.S. Federal Government agencies. Our technology and industry expertise enables us to provide a wide spectrum of services and solutions that assist our customers in achieving their program goals. We deliver these complex services and solutions by leveraging our skills across eight core capabilities:

 

    Cloud Computing and IT Infrastructure Optimization

 

    Cybersecurity and Information Assurance

 

    Engineering and Logistics Support

 

    Enterprise Information Management and Advanced Analytics

 

    Health IT and Medical Support

 

    IT Service Management

 

    Modeling, Training and Simulation

 

    Agile Development and Integration

Our team of highly skilled professionals is committed to service excellence and delivers innovative, cost-effective enterprise services and solutions on time and within budget. We are focused on reshaping the way services and solutions are delivered to our customers in order to proactively understand and meet their mission needs and enable them to rapidly adapt to dynamic environments. Headquartered in Reston, Virginia, the Company currently operates in more than 100 locations around the globe.

Key Financial Metrics

Prime Contractor Revenue

The following table shows our revenue derived from contracts on which we serve as a prime contractor.

 

     Three months ended March 31,  
     2016     2015  

Revenue derived from prime contracts

     94     91

Customer Group Revenue

The following table shows our revenue from the customer groups listed as a percentage of total revenue for the periods shown.

 

     Three months ended March 31,  
     2016     2015  

Department of Defense and intelligence agencies

     63     60

U.S. Federal civilian agencies

     37     40

Contract Type Revenue

Our services and solutions are provided under three types of contracts: time-and-materials; cost-plus fee; and firm fixed-price. Our contract mix varies from year to year due to numerous factors including our business strategies and U.S. Federal Government procurement objectives.

 

10


Table of Contents

The following table shows our revenue from each of these types of contracts as a percentage of our total revenue for the periods shown.

 

     Three months ended March 31,  
     2016     2015  

Time-and-materials

     17     24

Cost-plus fee

     59     45

Firm fixed-price

     24     31

The amount of risk and potential reward varies under each type of contract. Under time-and-materials contracts, we are paid a fixed hourly rate by labor category. To the extent that our actual labor costs vary significantly from the negotiated hourly rates, we may generate more or less than the targeted amount of profit. We are typically reimbursed for other contract direct costs and expenses at our cost, and typically receive no fee on those costs. For cost-plus fee contracts, there is limited financial risk, because we are reimbursed all our allowable costs, therefore the profit margins tend to be lower on cost-plus fee contracts. Under firm fixed-price contracts, we perform specific tasks or provide specified goods for a predetermined price. Compared to time-and-materials and cost-plus fee contracts, firm fixed-price service contracts generally offer higher profit margin opportunities but involve greater financial risk because we would bear the impact of potential cost overruns in return for the full benefit of any cost savings.

Contract Backlog

 

     As of  
     March 31, 2016      December 31, 2015  
     (in millions)  

Funded backlog

   $ 147       $ 147   

Total backlog

   $ 501       $ 552   

We define backlog as our estimate of the remaining future revenue from existing signed contracts over the remaining base contract performance period and from the option periods of those contracts that we believe are more likely than not to be exercised. Our backlog does not include any estimate of future potential delivery orders that might be awarded under our GWAC, agency-specific IDIQ, or other multiple-award contract vehicles. We define funded backlog as the portion of backlog for which funding currently is appropriated and obligated to us under a contract or other authorization for payment signed by an authorized purchasing agency, less the amount of revenue we have previously recognized. Our funded backlog does not represent the full potential value of our contracts, as Congress often appropriates funds for a particular program or agency on a quarterly or yearly basis, even though the contract may provide for the provision of services over a number of years. We define unfunded backlog, not included above, as the total backlog less the funded backlog. Unfunded backlog includes values for contract options that have been priced but not yet funded. Additional information on how we determine backlog is included in our Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the SEC.

Results of Operations

Three Months Ended March 31, 2016 Compared to Three Months Ended March 31, 2015

The following table sets forth certain items from our consolidated statements of income and expresses each item in dollars and as a percentage of revenue for the periods indicated:

 

     Three months ended March 31,  
     2016      2015      2016     2015  
     (in thousands)      (as a percentage of revenue)  

Revenue

   $ 83,655       $ 80,968         100.0     100.0

Operating expenses:

          

Cost of revenue

     69,987         67,602         83.7        83.5   

General and administrative expenses

     6,129         6,629         7.3        8.2   

Depreciation and amortization

     1,792         2,089         2.1        2.6   

Acquisition and integration related expenses

     —           230         —          0.2   
  

 

 

    

 

 

    

 

 

   

 

 

 

Total operating expenses

     77,908         76,550         93.1        94.5   
  

 

 

    

 

 

    

 

 

   

 

 

 

Operating income

     5,747         4,418         6.9        5.5   

Interest expense, net 

     190         238         0.2        0.3   
  

 

 

    

 

 

    

 

 

   

 

 

 

Income before income taxes

     5,557         4,180         6.7        5.2   

Provision for income taxes

     2,224         1,775         2.7        2.2   
  

 

 

    

 

 

    

 

 

   

 

 

 

Net income

   $ 3,333       $ 2,405         4.0     3.0
  

 

 

    

 

 

    

 

 

   

 

 

 

 

11


Table of Contents

Revenue

For the three months ended March 31, 2016, revenue increased by 3.3%, or $2.7 million, over the same period a year ago. This increase is principally due to revenues derived under the expanded PEO Soldier program, CNOSS program, and other new awards. The increase was partially offset by completed contracts and reductions in staffing and scope of work on certain contracts.

NCI’s PEO Soldier program accounted for $13.2 million, or 15.8% of revenue, in the first quarter of 2016, up $4.8 million from $8.4 million, or 10.3% of revenue, in the first quarter of 2015. NCI’s CNOSS program accounted for $8.5 million, or 10.1% of revenue, in the first quarter of 2016, up $2.7 million from $5.8 million, or 7.1% of revenue, in the first quarter of 2015.

Cost of revenue

Cost of revenue for the three months ended March 31, 2016 was $70.0 million, or 83.7% of revenue, compared to $67.6 million, or 83.5% of revenue, for the three months ended March 31, 2015. The increase in cost of revenue was primarily the result of the increased revenue reported for the period.

General and administrative expenses

General and administrative expense decreased 7.6%, or $0.5 million, for the three months ended March 31, 2016, as compared to the same period a year ago. The decrease was primarily due to lower compensation and external service provider costs.

Depreciation and amortization

Depreciation and amortization expense was approximately $1.8 million and $2.1 million for the quarters ended March 31, 2016 and 2015, respectively. The decrease was primarily due to certain intangible assets becoming fully amortized in Q1 of 2015.

Interest expense, net

Interest expense, net, was $0.2 million and $0.2 million for the quarters ended March 31, 2016 and 2015, respectively. During the first quarter of 2016, we had a weighted average outstanding loan balance of $16.5 million which accrued interest at a weighted average borrowing rate of 2.5%. During the first quarter of 2015, we had a weighted average outstanding loan balance of $28.6 million which accrued interest at a weighted average borrowing rate of 2.3%.

Provision for income taxes

Provision for income taxes increased by $0.5 million in the three months ended March 31, 2016, as compared to the three months ended March 31, 2015. This increase was due to higher operating income for the period ended March 31, 2016, offset by a lower effective tax rate. The effective income tax rate for the quarters ended March 31, 2016 and 2015 was approximately 40.0% and 42.5%, respectively. The decrease in the effective income tax rate is due to changes in the blended state income tax rate and state apportionment factors.

Liquidity and Capital Resources

Our primary liquidity needs are for financing working capital, capital expenditures, stock repurchases, and making selective strategic acquisitions. Historically, we have relied primarily on our cash flow from operations and borrowings under our credit facility to provide the capital for our liquidity needs. As part of our growth strategy, we may pursue acquisitions that could require us to incur additional debt or issue new equity. We expect the combination of our current cash, cash flow from operations, and the available borrowing capacity under our credit facility to continue to meet our normal working capital, capital expenditures and other cash requirements.

During the three months ended March 31, 2016, the balance of accounts receivable increased by $8.9 million to $68.9 million at the end of the quarter. Days sales outstanding of accounts receivable (DSO) increased 9 days to 75 days at March 31, 2016 as compared to

 

12


Table of Contents

66 days at December 31, 2015. The increase in DSO was mostly attributable the timing of invoice submission and the payments related to the transition to NCI’s new PEO Soldier program. As of March 31, 2016, $20.5 million was due under the credit facility, as compared to $10.0 million outstanding as of December 31, 2015, reflecting $10.5 million of net borrowings during the first three months of 2016 due to the timing issues described previously. Net cash used by operating activities was $8.2 million at March 31, 2016 and was used to meet working capital requirements, primarily higher accounts receivable.

Our board of directors authorized management to repurchase up to $25.0 million of our Class A common stock pursuant to a stock repurchase program. If shares are repurchased, the shares will be repurchased pursuant to open market purchases, privately negotiated transactions, or block transactions. We have no obligation to repurchase shares under the authorization, and the timing, actual number and value of the shares which are repurchased (and the manner of any such repurchase) will be at the discretion of management and will depend on a number of factors, including the price of our common stock, our Company’s cash needs, borrowing capacity under our credit facility, interest rates, and our financial performance and position. We may suspend or discontinue repurchases at any time.

During 2015 and the three months ended March 31, 2016, we did not repurchase any shares. At March 31, 2016, we had $16.7 million remaining under the board of directors’ authorization for share repurchases.

Credit Facility: Our senior credit facility, amended in December 2014, and referred to herein as the “credit facility,” consists of a revolving line of credit with a borrowing capacity of up to an $80.0 million principal amount, and a $45.0 million accordion feature allowing us to increase our borrowing capacity to up to a $125.0 million principal amount, subject to obtaining commitments for the incremental capacity from existing or new lenders. The outstanding borrowings are collateralized by a security interest in substantially all the Company’s assets. The lenders also require a direct assignment of all contracts at the lenders’ discretion. The outstanding balance under the credit facility accrues interest based on one-month LIBOR plus an applicable margin, ranging from 210 to 310 basis points, based on the ratio of our outstanding senior funded debt to Earnings before Interest, Taxes, Depreciation, and Amortization (EBITDA) as defined in the credit facility agreement.

The credit facility allows us to use borrowings thereunder of up to $17.5 million to repurchase shares of our common stock. Funds borrowed under the credit facility may be used to finance possible future acquisitions, for working capital requirements, for stock repurchases, for cash dividends or for general corporate uses.

The loan interest accrual rate is set monthly at one-month LIBOR plus a set amount per the credit facility.

The credit facility contains various restrictive covenants that restrict, among other things, our ability to incur or guarantee additional debt; make certain distributions, investments and other restricted payments such as dividends; enter into transactions with certain affiliates; create or permit certain liens; and consolidate, merge, or sell assets. In addition, the credit facility contains certain financial covenants that require us to maintain a minimum tangible net worth; maintain a minimum fixed charge coverage ratio; maintain a minimum funded debt to earnings ratio; and limit capital expenditures below certain thresholds. There are no restrictions on our retained earnings in the credit facility.

We intend to amend and extend our credit facility before the current facility expires in January 2017. As of March 31, 2016, we were in compliance with all our loan covenants.

Off-Balance Sheet Arrangements

We do not have any material off-balance sheet arrangements.

Critical Accounting Policies

There have been no significant changes to our Critical Accounting Policies during the first quarter of 2016. Refer to the Critical Accounting Policies section in our Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the SEC.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

The Company’s exposure to market risk relates to changes in interest rates for borrowings under its credit facility. For the quarter ended March 31, 2016, a change of one percentage point in interest rates would have changed NCI’s interest expense or cash flows by less than $0.1 million. This estimate is based on our average balances for the period.

Additionally, the Company is subject to credit risks associated with our cash, cash equivalents, and accounts receivable. NCI believes that the concentration of credit risk with respect to cash equivalents is limited due to the high credit quality of these investments. NCI’s investment policy requires that the Company invest excess cash in high-quality investments, which preserve principal, provide liquidity, and minimize investment risk. NCI also believes that its credit risk associated with accounts receivable is limited as they are primarily with the U.S. Federal Government or prime contractors working for the U.S. Federal Government.

 

13


Table of Contents

Item 4. Controls and Procedures

Evaluation of the Effectiveness of Disclosure Controls and Procedures

As of March 31, 2016, under the supervision and with the participation of NCI’s management, including our Chief Executive Officer and our Chief Financial Officer, the Company had evaluated the effectiveness of its disclosure controls and procedures, as defined in Rule 13a-15(e) of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). Based on this evaluation, NCI’s Chief Executive Officer and Chief Financial Officer concluded that the Company’s disclosure controls and procedures were effective, as of March 31, 2016, such that the information that is required to be disclosed in NCI’s reports filed with the SEC (i) is recorded, processed, summarized and reported within the time periods specified in SEC rules and forms and (ii) is accumulated and communicated to management, including NCI’s Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

The Company made no change to its internal control over financial reporting (as defined in Rule 13a-15(f) of the Exchange Act) identified in connection with the evaluation required by Rule 13a-15(d) under the Exchange Act during the three months ended March 31, 2016 that has materially affected, or is reasonably likely to materially affect, its internal control over financial reporting.

 

14


Table of Contents

PART II

OTHER INFORMATION

Item 1. Legal Proceedings

The Company is party to various legal actions, claims, government inquiries, and audits resulting from the normal course of business. The Company currently believes that the probability is remote that any resulting liability will have a material effect on the Company’s financial position, results of operations, or cash flows.

Item 1A. Risk Factors

There have been no significant changes in our risk factors from those discussed in Item 1A. “Risk Factors” included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2015, as filed with the SEC.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

None

Item 3. Defaults Upon Senior Securities

None

Item 4. Mine Safety Disclosures

Not applicable

Item 5. Other Information

None

 

15


Table of Contents

Item 6. Exhibits

 

Number

  

Description

    2.1    Stock Purchase Agreement among NCI Information Systems, Inc. (“NCIIS”), a wholly owned subsidiary of NCI, Inc., and stockholders of AdvanceMed Corporation dated as of February 24, 2011 (incorporated herein by reference from Exhibit 2.1 to registrant’s Current Report on Form 8-K, as filed with the Commission on April 4, 2011)
    3.1    Amended and Restated Certificate of Incorporation of the Registrant (incorporated herein by reference from Exhibit 3.1 to registrant’s Registration Statement on Form S-1 (File No. 333-127006), as filed with the Commission on October 4, 2005, as amended).
    3.2    Bylaws of the Registrant (incorporated herein by reference from Exhibit 3.2 to registrant’s Registration Statement on Form S-1 (File No. 333-127006), as filed with the Commission on July 29, 2005).
    4.1    Specimen Class A Common Stock Certificate (incorporated herein by reference from Exhibit 4.1 to registrant’s Registration Statement on Form S-1 (File No. 333-127006), as filed with the Commission on October 20, 2005, as amended).
    4.2*    NCI, Inc. Amended and Restated 2005 Performance Incentive Plan (incorporated herein by reference from Appendix A to registrant’s Definitive Proxy Statement on Schedule 14A, as filed with the Commission on April 30, 2009).
    4.3*    Form of Amended and Restated 2005 Performance Incentive Plan Notice of Stock Option Grant and Stock Option Agreement (incorporated herein by reference from Exhibit 4.2 to registrant’s Current Report on Form 8-K, as filed with the Commission on March 12, 2009).
  31.1‡    Certification of the Chief Executive Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
  31.2‡    Certification of the Chief Financial Officer pursuant to rule 13a-14(a) of the Securities Exchange Act of 1934, as amended.
  32.1‡    Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.
101.INS    XBRL Instance Document
101.SCH    XBRL Extension Schema
101.CAL    XBRL Extension Calculation Linkbase
101.DEF    XBRL Extension Definition Linkbase
101.LAB    XBRL Extension Label Linkbase
101.PRE    XBRL Extension Presentation Linkbase

 

Included with this filing.
* Management Contract or Compensatory Plan or Arrangement.

 

16


Table of Contents

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

     

NCI, Inc.

     

Registrant

Date: April 29, 2016

   

By:

 

/s/ LUCAS J. NAREL

     

Lucas J. Narel

      Executive Vice President, Chief Financial Officer and Treasurer
     

(Principal Financial Officer)

     

(Principal Accounting Officer)

 

17